Table 4. Disease progression correlates... | American Society of Hematology

Table 4.

Disease progression correlates with CD94 only

Parameters for correlation	Nonprogressive, N = 8	Progressive, N = 11	Spearman correlation coefficient	P
Male-female ratio	6:2	10:1	0.22	.38
Median age, y	50	57	0.19	.42
CD56⁺	4	6	0.04	.85
KIR2DL4⁺	5	7	0.01	.96
KIR2D⁺	3	4	−0.01	.96
KIR3D⁺	3	4	−0.01	.96
CD94⁺	7	3	−0.59	.007
NKG2A⁺	3	4	−0.01	.96
NKG2C⁺	2	1	−0.22	.38
NKG2D⁺	0	0	NA	NA
NKG2F⁺	2	0	−0.40	.08
Early stage, I	6	8	−0.01	.97
Median WBC, 10³/μL	5.2	6.8	0.37	.17
Median HB, g/dL	12.1	12.6	0.05	.83
Median PLT, 10³/μL	234	237	−0.02	.94
Median LDH, U/L	420	525	0.45	.10

Parameters for correlation	Nonprogressive, N = 8	Progressive, N = 11	Spearman correlation coefficient	P
Male-female ratio	6:2	10:1	0.22	.38
Median age, y	50	57	0.19	.42
CD56⁺	4	6	0.04	.85
KIR2DL4⁺	5	7	0.01	.96
KIR2D⁺	3	4	−0.01	.96
KIR3D⁺	3	4	−0.01	.96
CD94⁺	7	3	−0.59	.007
NKG2A⁺	3	4	−0.01	.96
NKG2C⁺	2	1	−0.22	.38
NKG2D⁺	0	0	NA	NA
NKG2F⁺	2	0	−0.40	.08
Early stage, I	6	8	−0.01	.97
Median WBC, 10³/μL	5.2	6.8	0.37	.17
Median HB, g/dL	12.1	12.6	0.05	.83
Median PLT, 10³/μL	234	237	−0.02	.94
Median LDH, U/L	420	525	0.45	.10

NA indicates not applicable.